LENZ Therapeutics, Inc. (LENZ) Misses Q1 EPS by 132c

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q1 EPS of ($1.32). Revenue for the quarter came in at $1.9 million.

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

You May Also Be Interested In

• UBS Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy
• GMR Solutions to reprice $2.9B term loan, pay down $200M in debt
• Saudi Arabia shuts East-West Pipeline after attacks